APPLICATION
ANDA211175
TYPE
ANDA
ORIGINAL APPROVAL
2019-01-28
LATEST ACTION
2019-01-28
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued
Products
TAZAROTENEDiscontinued
TAZAROTENE 0.1% · CREAM · TOPICAL
Approval history
2019-01-28UNKNOWN · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.